supplier
BioCryst Ireland Limited
as a supplier
3 recorded awards from 2 buyers , between 24 Mar 2025 and 24 Mar 2025.
awards won
3
exclusive
33%
1 sole-winner awards
median award
·
no comparable value
largest
·
no comparable value
“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.
No median is shown because every award here carries a framework ceiling rather than a settled price. A ceiling is the most that could be spent across every supplier on the agreement, so averaging them would overstate this organisation’s work, often by an order of magnitude. The individual values are listed below as published.
sells to
| buyer | awards |
|---|---|
| NHS England | 2 |
| Belfast Health and Social Care Trust | 1 |
contracts won
| contract | buyer | value | awarded |
|---|---|---|---|
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender shared | NHS England | £1,241,520,444 | 24 Mar 2025 |
| NHS Framework Agreement for Branded Medicines - Proprietary Category Tender - 1 May 2025 shared | NHS England | · | 22 Apr 2025 |
| BEROTRALSTAT 150 mg Tablets 28 Tablet Box | BELFAST HEALTH AND SOCIAL CARE TRUST | · | 19 Feb 2024 |